Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-α

BACKGROUND: The anti-TNFα therapy has been since its approval by the FDA, along with nonsteroidal antiinflammatory drugs (NSAIDs), one of the most important therapies for control of spondyloarthritis (SpA). The onset of Lupus Like Syndrome (LLS) has been described in patients with rheumatoid arthrit...

Descripción completa

Detalles Bibliográficos
Autores principales: Puertas-Abreu, Eduardo, Polanco, Elaudi Rodríguez, Azocar, Miriam, Mundarain, Luis Antonio, Nuñez-Sotelo, Concepción Morelia, Montaño, Rafael, Vivas, Freddy Herrera, Noguera, Zair Tovar, Marín, Francisco, Bellorin, Omar, Rivas, José Gregorio, Toro, Eduardo, Benzaquen, Eugenia, Rauseo, Mayra, Gutiérrez González, Luis Arturo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295660/
https://www.ncbi.nlm.nih.gov/pubmed/22336076
http://dx.doi.org/10.1186/1755-7682-5-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295660/
https://www.ncbi.nlm.nih.gov/pubmed/22336076
http://dx.doi.org/10.1186/1755-7682-5-7

Ejemplares similares